NCT06379542View on ClinicalTrials.gov

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

PHASE3RecruitingINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Respiratory Infection
Interventions
DRUG

XC8

40 mg/day or 80 mg/day for 7-14 days

DRUG

Placebo

2 tablets/day for 7-14 days

Trial Locations (6)

192071

RECRUITING

"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 44", Saint Petersburg

194223

RECRUITING

ArsVite North-West, LLC, Saint Petersburg

196158

RECRUITING

PiterKlinika LLC, Saint Petersburg

196191

RECRUITING

"St. Petersburg State Budgetary Healthcare Institution City Pediatric Polyclinic No. 35", Saint Petersburg

614066

RECRUITING

City Pediatric Outpatient Clinic number 5, Perm

614070

RECRUITING

Professors' Clinic LLC., Perm

All Listed Sponsors
lead

Valenta Pharm JSC

INDUSTRY